Immediate Impact

1 by Nobel laureates 64 standout
Sub-graph 1 of 24

Citing Papers

Therapeutic advances in rheumatoid arthritis
2024 Standout
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2023 Standout
2 intermediate papers

Works of J Lacasa being referenced

Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in prevention
2008
Paradoxical Response to Antituberculous Therapy in Infliximab-Treated Patients with Disseminated Tuberculosis
2005

Author Peers

Author Last Decade Papers Cites
J Lacasa 137 135 140 11 300
William T. McGaw 73 28 150 11 269
Jiro Sasaki 85 84 76 26 312
Bahar Sezer 80 61 52 14 285
P Ammatuna 66 29 140 18 290
Mark J. Kutcher 80 17 151 15 360
Maria Luisa Gainza‐Cirauqui 36 57 38 15 332
Ellen Poeschl 157 91 49 9 370
Jehn‐Shyun Huang 60 102 35 8 325
Xiaoqiong Tang 121 31 69 21 298
Monisha Billings 38 36 49 12 366

All Works

Loading papers...

Rankless by CCL
2026